AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
May 10, 2013
30016_dirs_2013-05-10_9fc37c03-291a-450b-942c-0efd2e62c647.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-05-08
Reporting Person: SZOSTAK M ANNE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-08 | Deferred Stock Unit | $ | A | 429 | Acquired | Common Stock (429) | Direct | |
| 2013-05-08 | Non-Qualified Stock Option (right to buy) | $87.36 | A | 4395 | Acquired | 2023-05-07 | Common Stock (4395) | Direct |
Footnotes
F1: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% on the date of IDEXX Laboratories, Inc.'s next annual stockholders' meeting, which is currently scheduled to be held on 05/07/2014, and are payable as common stock one year following the Director's resignation from the Board of Directors.
F2: Grant of options to buy shares of common stock that vest on the date of IDEXX Laboratories, Inc.'s next annual stockholders' meeting, which is currently scheduled to be held on 05/07/2014.